Synonyms: Aerosporin®
polymyxin B is an approved drug (FDA (1964, no prior history available))
Compound class:
Peptide
Comment: Polymyxin B is a mixture of the polypeptides polymyxins B1 and B2, both obtained from Bacillus polymyxa strains. It is an antibacterial compound that demonstrates bactericidal action against almost all Gram-negative bacilli except the Proteus group.
|
|
Classification ![]() |
|
Compound class | Peptide |
Approved drug? | Yes. FDA (1964) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names ![]() |
|
INN number | INN |
490 | polymyxin B |
Synonyms ![]() |
Aerosporin® |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
Polymyxin B |
Other databases | |
ChEMBL Ligand | CHEMBL241797 |
GtoPdb PubChem SID | 381745019 |
PubChem CID | 4868 |
Search Google for chemical match using the InChIKey | WQVJHHACXVLGBL-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | WQVJHHACXVLGBL |
Search PubMed clinical trials | polymyxin B |
Search PubMed titles | polymyxin B |
Search PubMed titles/abstracts | polymyxin B |
UniChem Compound Search for chemical match using the InChIKey | WQVJHHACXVLGBL-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WQVJHHACXVLGBL-UHFFFAOYSA-N |